Amylyx class action Relyvrio, page-31

So it was reported on here that big pharmas look out for others submitting ODD applications, well PAA did this and it appears no big pharma took any norptice, sp at the time 9 cents
It was posted on here big pharmas look out for trial results, PAA have reported on their trial which shows great safety and great data on life extension and still no big pharma wants to step up, sp between 28 and 52 cents but now back to 28 cents,

So now posters are saying oh wait until ODD outcome which could take up to 90 days.

Well if a big pharma came forward right now and took a stake in PAA to cover the $30m for 108m shares seems to be a very small investment, should they wait until the ODD and if approved one
would think the sp would at least nearly double if not go even higher meaning if stake taken in the company the number of shares to be issued to them goes down.

As for double checking the mpl trial data and crossing the T's surely this was done prior to putting out the trial data outcome announcements